Despite Confusion, Palatin's Phase II Data Solid
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. It programs are based on molecules that modulate the activity of the melanocortin and... More
Industry: Diagnostic Substances
Country: United States
Other News & PR